Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102219803A details a novel nitrone-based route for Ezetimibe intermediates, offering superior stereocontrol and reduced raw material consumption for pharmaceutical manufacturing.
Novel boron-catalyzed method for meta-cyano pyridines. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1169418A details a novel Lewis acid-catalyzed condensation for polyene esters, offering superior gamma-selectivity and cost reduction in carotenoid manufacturing compared to Wittig reactions.
Patent CN116003407A reveals a scalable Zolpidem synthesis using PBr3-Lewis Acid catalysis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN103360225B details a green Fries rearrangement method. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN115850048B reveals metal-free HBeta zeolite catalysis for 2-aryl butenones. Delivers high purity, water-based solvent systems, and significant supply chain cost optimization.
Patent CN103193608A details a high-yield veratraldehyde synthesis route offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel catalytic hydrolysis method for 17-hydroxy corticosteroids reducing 21-position byproducts and simplifying purification for reliable API intermediate supply.
Patent CN105130982A reveals efficient synthesis route. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN106146535A reveals a novel Lewis acid-catalyzed route for Everolimus. This method ensures high purity, reduced steps, and scalable supply chain reliability for global buyers.
Patent CN110511166B details a green one-pot synthesis using recyclable Amberlyst-15 in water, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Novel CrCl3-catalyzed route for (S)-phenylglycinol hydrochloride. Enhances purity and reduces costs for pharmaceutical intermediate manufacturing.
Patent CN111825612B reveals a cost-effective four-step route for high-purity quinoxaline intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN102924380B reveals a high-purity imidocarb synthesis route. This report analyzes cost reduction in veterinary drug manufacturing and supply chain reliability for global procurement teams.
Patent CN1254340A reveals a safer route for Styrene Phosphonic Acid production, eliminating hazardous HCl by-products and offering significant cost reduction in fine chemical manufacturing.
Novel catalytic method for Fmoc-Hyp(tBu)-OH production ensuring high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN102256986B details advanced purification for thermal stability. Offers supply chain reliability and cost reduction for agrochemical manufacturing partners globally.